Literature DB >> 8978350

Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats.

I De Blaauw1, N E Deutz, R R van der Hulst, M F von Meyenfeldt.   

Abstract

BACKGROUND & AIMS: Glutamine is an essential amino acid for rapidly dividing cells such as enterocytes. The progress of cancer is associated with a decrease of arterial and muscle glutamine concentrations. The aim of this study was to test whether increasing tumor loads affect gut intracellular glutamine handling, protein turnover, and gut absorptive and barrier function.
METHODS: Methylcholantrene-induced tumor-bearing rats were studied with a subcutaneous tumor load of 5%-15% or 15%-30% of body weight. Portal drained visceral net uptake or release of energy substrates, amino acids, and intestinal protein turnover were studied. Gut absorptive capacity and permeability was assessed by the urinary recovery of 3-O-methyl-D-glucose or lactulose-rhamnose ratio after an oral gavage.
RESULTS: In tumor-bearing rats, the net uptake of energy substrates (ketones and glutamine) and net protein synthesis increased across the portal drained viscera, whereas mucosal glutamine concentrations decreased. Absorptive capacity remained unchanged in both tumor-bearing groups. However, the lactulose-rhamnose ratio increased with increasing tumor load, indicating loss of gut barrier function. This was not related to changes in villus height, crypt depth, or changes in mucosal cell populations but to decreased intracellular polyamine concentrations.
CONCLUSIONS: The presence of a methylcholantrene tumor leads to altered mucosal glutamine metabolism and loss of gut barrier function possibly related to disturbed proliferation or differentiation of enterocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8978350     DOI: 10.1016/s0016-5085(97)70226-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients.

Authors:  Mitchell P Fink
Journal:  Intensive Care Med       Date:  2002-01-12       Impact factor: 17.440

Review 2.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.

Authors:  Katharina S Kuhn; Maurizio Muscaritoli; Paul Wischmeyer; Peter Stehle
Journal:  Eur J Nutr       Date:  2009-11-21       Impact factor: 5.614

3.  Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Haichao Wang; Steven A Blau; Thanjavur S Ravikumar; Ping Wang
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

4.  Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate.

Authors:  E C Clark; S D Patel; P R Chadwick; G Warhurst; A Curry; G L Carlson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

5.  Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats.

Authors:  Xiao-Ting Wu; Jie-Shou Li; Xiao-Fei Zhao; Ning Li; Yu-Kui Ma; Wen Zhuang; Yong Zhou; Gang Yang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.